BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okuda K. Hepatocellular carcinoma. J Hepatol. 2000;32:225-237. [PMID: 10728807 DOI: 10.1016/s0168-8278(00)80428-6] [Cited by in Crossref: 380] [Cited by in F6Publishing: 125] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Jin YJ, Byun S, Han S, Chamberlin J, Kim D, Kim MJ, Lee Y. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors. BMC Med Genomics 2019;12:175. [PMID: 31856847 DOI: 10.1186/s12920-019-0635-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kawabe N, Hashimoto S, Nakano T, Nakaoka K, Fukui A, Yoshioka K. Transcatheter arterial infusion chemotherapy with cisplatin in combination with transcatheter arterial chemoembolization decreases intrahepatic distant recurrence of unresectable hepatocellular carcinoma. JGH Open 2021;5:705-11. [PMID: 34124389 DOI: 10.1002/jgh3.12573] [Reference Citation Analysis]
3 Blum HE. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol. 2005;11:7391-7400. [PMID: 16437707 DOI: 10.3748/wjg.v11.i47.7391] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 94] [Article Influence: 2.3] [Reference Citation Analysis]
4 Nakamoto S, Kanda T, Wu S, Shirasawa H, Yokosuka O. Hepatitis C virus NS5A inhibitors and drug resistance mutations. World J Gastroenterol 2014; 20(11): 2902-2912 [PMID: 24659881 DOI: 10.3748/wjg.v20.i11.2902] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 84] [Article Influence: 11.6] [Reference Citation Analysis]
5 Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM, Zheng SS. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29:1810-1816. [PMID: 21678027 DOI: 10.1007/s12032-011-0004-z] [Cited by in Crossref: 360] [Cited by in F6Publishing: 388] [Article Influence: 32.7] [Reference Citation Analysis]
6 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-1125/1/142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14:4300-4308. [PMID: 18666317 DOI: 10.3748/wjg.v14.i27.4300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ezzat WM, Amr KS. Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention. World J Hepatol 2016; 8(30): 1251-1261 [PMID: 27843535 DOI: 10.4254/wjh.v8.i30.1251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
9 Villanueva A, Toffanin S, Llovet JM. Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps. Curr Opin Oncol. 2008;20:444-453. [PMID: 18525342 DOI: 10.1097/CCO.0b013e328302c9e9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
10 Liu X, Zhu L, Ma J, Qiao X, Zhu D, Liu L, Leng X. Target-specific delivery of siRNA into hepatoma cells' cytoplasm by bifunctional carrier peptide. Drug Deliv Transl Res 2017;7:147-55. [PMID: 27896668 DOI: 10.1007/s13346-016-0348-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Zhang WY, Cai N, Ye LH, Zhang XD. Transformation of human liver L-O2 cells mediated by stable HBx transfection. Acta Pharmacol Sin. 2009;30:1153-1161. [PMID: 19578387 DOI: 10.1038/aps.2009.99] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
12 Kirimlioglu H, Dvorchick I, Ruppert K, Finkelstein S, Marsh JW, Iwatsuki S, Bonham A, Carr B, Nalesnik M, Michalopoulos G. Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology. 2001;34:502-510. [PMID: 11526535 DOI: 10.1053/jhep.2001.26633] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
13 Ishikawa T. Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma. World J Gastroenterol 2012; 18(17): 2005-2008 [PMID: 22563186 DOI: 10.3748/wjg.v18.i17.2005] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
14 Phillips RJ, Helbig KJ, Hoek KHVD, Seth D, Beard MR. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 2012; 18(26): 3389-3399 [PMID: 22807608 DOI: 10.3748/wjg.v18.i26.3389] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
15 Machida K, Tsukamoto H, Mkrtchyan H, Duan L, Dynnyk A, Liu HM, Asahina K, Govindarajan S, Ray R, Ou JH, Seki E, Deshaies R, Miyake K, Lai MM. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc Natl Acad Sci USA. 2009;106:1548-1553. [PMID: 19171902 DOI: 10.1073/pnas.0807390106] [Cited by in Crossref: 157] [Cited by in F6Publishing: 159] [Article Influence: 12.1] [Reference Citation Analysis]
16 Cheng J, Liu Y, Hong Y, Wang JJ, Yang Q. Screening and identification of genes trans-regulated by hepatitis C virus NC3 protein with microarray assay. Shijie Huaren Xiaohua Zazhi 2003; 11(7): 930-934 [DOI: 10.11569/wcjd.v11.i7.930] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
17 Song TJ, Fong Y, Cho SJ, Gönen M, Hezel M, Tuorto S, Choi SY, Kim YC, Suh SO, Koo BH. Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysis. J Surg Oncol. 2012;106:84-88. [PMID: 22234941 DOI: 10.1002/jso.23036] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
18 de Oliveria Andrade LJ, D’Oliveira A, Melo RC, De Souza EC, Costa Silva CA, Paraná R. Association between hepatitis C and hepatocellular carcinoma. J Glob Infect Dis. 2009;1:33-37. [PMID: 20300384 DOI: 10.4103/0974-777x.52979] [Cited by in Crossref: 93] [Cited by in F6Publishing: 45] [Article Influence: 8.5] [Reference Citation Analysis]
19 Liu Y, Wang WM, Lu YF, Feng L, Li L, Pan MZ, Sun Y, Suen CW, Guo W, Pang JX, Zhang JF, Fu WM. Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma. Oncotarget 2017;8:50655-64. [PMID: 28881591 DOI: 10.18632/oncotarget.16901] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
20 Yan F, Wang XM, Pan C, Ma QM. Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells. World J Gastroenterol 2009; 15(12): 1443-1451 [PMID: 19322916 DOI: 10.3748/wjg.15.1443] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
21 Maruyama H, Yoshikawa M, Yokosuka O. Current role of ultrasound for the management of hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1710-1719 [PMID: 18350602 DOI: 10.3748/wjg.14.1710] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
22 Kanmura S, Uto H, Sato Y, Kumagai K, Sasaki F, Moriuchi A, Oketani M, Ido A, Nagata K, Hayashi K. The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol. 2010;45:459-467. [PMID: 20012107 DOI: 10.1007/s00535-009-0160-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
23 Wang H, Pan K, Zhang HK, Weng DS, Zhou J, Li JJ, Huang W, Song HF, Chen MS, Xia JC. Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2008;134:535-541. [PMID: 17917742 DOI: 10.1007/s00432-007-0316-8] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
24 Malik S, Bhatnagar S, Chaudhary N, Katare DP, Jain SK. DEN+2-AAF-induced multistep hepatotumorigenesis in Wistar rats: supportive evidence and insights. Protoplasma. 2013;250:175-183. [PMID: 22456951 DOI: 10.1007/s00709-012-0392-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
25 Zeng Z, Ren J, O’Neil M, Zhao J, Bridges B, Cox J, Abdulkarim B, Schmitt TM, Kumer SC, Weinman SA. Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation. BMC Cancer. 2012;12:584. [PMID: 23216644 DOI: 10.1186/1471-2407-12-584] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
26 Vongchan P, Wutti-In Y, Sajomsang W, Gonil P, Kothan S, Linhardt RJ. N,N,N-Trimethyl chitosan nanoparticles for the delivery of monoclonal antibodies against hepatocellular carcinoma cells. Carbohydr Polym. 2011;85:215-220. [PMID: 21552341 DOI: 10.1016/j.carbpol.2011.02.018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
27 Cao XL, Li H, Yu XL, Liang P, Dong BW, Fan J, Li M, Liu FY. Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature. PLoS One 2013;8:e82448. [PMID: 24349287 DOI: 10.1371/journal.pone.0082448] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
28 Brahmi D, Bouaziz C, Ayed Y, Ben Mansour H, Zourgui L, Bacha H. Chemopreventive effect of cactus Opuntia ficus indica on oxidative stress and genotoxicity of aflatoxin B1. Nutr Metab (Lond). 2011;8:73. [PMID: 22008149 DOI: 10.1186/1743-7075-8-73] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
29 Ariyasu T, Tanaka T, Fujioka N, Yanai Y, Yamamoto S, Yamauchi H, Ikegami H, Ikeda M, Kurimoto M. Effects of interferon-alpha subtypes on the TH1/TH2 balance in peripheral blood mononuclear cells from patients with hepatitis virus infection-associated liver disorders. In Vitro Cell Dev Biol Anim. 2005;41:50-56. [PMID: 15926860 DOI: 10.1290/0501008.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
30 Waly Raphael S, Yangde Z, Yuxiang C. Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol 2012;2012:421673. [PMID: 22655206 DOI: 10.5402/2012/421673] [Cited by in Crossref: 25] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
31 Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol. 2001;153:1023-1034. [PMID: 11381087 DOI: 10.1083/jcb.153.5.1023] [Cited by in Crossref: 208] [Cited by in F6Publishing: 206] [Article Influence: 9.9] [Reference Citation Analysis]
32 Machida K, Tsukamoto H, Liu JC, Han YP, Govindarajan S, Lai MM, Akira S, Ou JH. c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair. Hepatology. 2010;52:480-492. [PMID: 20683948 DOI: 10.1002/hep.23697] [Cited by in Crossref: 65] [Cited by in F6Publishing: 235] [Article Influence: 5.4] [Reference Citation Analysis]
33 Huang M, Wang L, Chen J, Bai M, Zhou C, Liu S, Lin Q. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery. Int J Oncol 2016;48:2144-54. [PMID: 26984380 DOI: 10.3892/ijo.2016.3421] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
34 Jiao W, Miyazaki K, Kitajima Y. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer. 2002;86:98-101. [PMID: 11857019 DOI: 10.1038/sj.bjc.6600017] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 5.4] [Reference Citation Analysis]
35 Zhang WY, Xu FQ, Shan CL, Xiang R, Ye LH, Zhang XD. Gene expression profiles of human liver cells mediated by hepatitis B virus X protein. Acta Pharmacol Sin 2009;30:424-34. [PMID: 19343061 DOI: 10.1038/aps.2009.22] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
36 Ocker M, Ganslmayer M, Zopf S, Gahr S, Janson C, Hahn EG, Herold C. Improvement of quantitative testing of liver function in patients with chronic hepatitis C after installment of antiviral therapy. World J Gastroenterol 2005; 11(35): 5521-5524 [PMID: 16222747 DOI: 10.3748/wjg.v11.i35.5521] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
37 Tsukamoto H, Mishra L, Machida K. Alcohol, TLR4-TGF-β antagonism, and liver cancer. Hepatol Int. 2014;8 Suppl 2:408-412. [PMID: 26201318 DOI: 10.1007/s12072-013-9489-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
38 Sheng SL, Wang Q, Huang G, Yu B, Qin WX. Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays. J Clin Lab Anal 2009;23:179-85. [PMID: 19455631 DOI: 10.1002/jcla.20316] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
39 Pan K, Zhao JJ, Wang H, Li JJ, Liang XT, Sun JC, Chen YB, Ma HQ, Liu Q, Xia JC. Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate. Int J Biol Sci 2010;6:639-48. [PMID: 20975822 DOI: 10.7150/ijbs.6.639] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
40 Buurman R, Sandbothe M, Schlegelberger B, Skawran B. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma. Eur J Med Res 2016;21:26. [PMID: 27342975 DOI: 10.1186/s40001-016-0217-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
41 Machida K. TLRs, Alcohol, HCV, and Tumorigenesis. Gastroenterol Res Pract. 2010;2010:518674. [PMID: 21331379 DOI: 10.1155/2010/518674] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
42 Lu CX, Nan KJ, Nie YL, Hai YN, Jiao M. Delisheng, a Chinese medicinal compound, exerts anti-proliferative and pro-apoptotic effects on HepG2 cells through extrinsic and intrinsic pathways. Mol Biol Rep 2010;37:3407-12. [PMID: 20012371 DOI: 10.1007/s11033-009-9930-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
43 Mu JS, Liu Y, Wang G, Cheng J, Duan HJ, Li K, Lu YY, Wang L, Wang HF. Cloning of genes transactivated by NS3 protein of HCV with suppressive and subtractive hybridization. Shijie Huaren Xiaohua Zazhi 2003; 11(4): 399-403 [DOI: 10.11569/wcjd.v11.i4.399] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
44 Takimoto M, Ohkoshi S, Ichida T, Takeda Y, Nomoto M, Asakura H, Naito A, Mori S, Hata K, Igarashi K. Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients. Dig Dis Sci. 2002;47:170-176. [PMID: 11837720 DOI: 10.1023/a:1013244326874] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
45 Chen LC, Lee WC, Ho CL, Chang YJ, Chen SJ, Chang CH. Biodistribution, Pharmacokinetics and Efficacy of 188Re(I)-Tricarbonyl-Labeled Human Serum Albumin Microspheres in an Orthotopic Hepatoma Rat Model. In Vivo 2018;32:567-73. [PMID: 29695562 DOI: 10.21873/invivo.11277] [Reference Citation Analysis]
46 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-11] [Cited by in Crossref: 91] [Cited by in F6Publishing: 58] [Article Influence: 9.1] [Reference Citation Analysis]
47 Paradis V, Bièche I, Dargère D, Laurendeau I, Laurent C, Bioulac Sage P, Degott C, Belghiti J, Vidaud M, Bedossa P. Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index. Am J Pathol. 2003;163:733-741. [PMID: 12875992 DOI: 10.1016/S0002-9440(10)63700-5] [Cited by in Crossref: 64] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
48 Lee MJ, Xu DY, Li H, Yu GR, Leem SH, Chu IS, Kim IH, Kim DG. Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma. Exp Mol Med 2012;44:214-24. [PMID: 22192927 DOI: 10.3858/emm.2012.44.3.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
49 Kurokohchi K, Watanabe S, Yoneyama H, Deguchi A, Masaki T, Himoto T, Miyoshi H, Mohammad HS, Kitanaka A, Taminato T, Kuriyama S. A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma. World J Gastroenterol 2008; 14(13): 2037-2043 [PMID: 18395903 DOI: 10.3748/wjg.14.2037] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
50 Machida K. Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus. Drug Deliv Transl Res 2013;3:152-64. [PMID: 25787983 DOI: 10.1007/s13346-012-0115-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
51 Shen LJ, Zhang HX, Zhang ZJ, Li JY, Chen MQ, Yang WB, Huang R. Detection of HBV, PCNA and GST-π in hepatocellular carcinoma and chronic liver diseases. World J Gastroenterol 2003; 9(3): 459-462 [PMID: 12632497 DOI: 10.3748/wjg.v9.i3.459] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
52 Matsuda Y. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1734-1740 [PMID: 18350604 DOI: 10.3748/wjg.14.1734] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
53 Szabó E, Páska C, Kaposi Novák P, Schaff Z, Kiss A. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol Oncol Res 2004;10:5-11. [PMID: 15029254 DOI: 10.1007/BF02893401] [Cited by in Crossref: 66] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
54 Machida K, Chen CL, Liu JC, Kashiwabara C, Feldman D, French SW, Sher L, Hyeongnam JJ, Tsukamoto H. Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus. J Gastroenterol Hepatol. 2012;27 Suppl 2:19-22. [PMID: 22320911 DOI: 10.1111/j.1440-1746.2011.07010.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
55 Ma HQ, Liang XT, Zhao JJ, Wang H, Sun JC, Chen YB, Pan K, Xia JC. Decreased expression of Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma. World J Gastroenterol 2009; 15(38): 4844-4848 [PMID: 19824122 DOI: 10.3748/wjg.15.4844] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
56 Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Tanaka S, Nishina S, Nakanishi Y, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yagi T, Yamamoto K. Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 2009;9:240. [PMID: 19615090 DOI: 10.1186/1471-2407-9-240] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 6.5] [Reference Citation Analysis]
57 Zhang HY, Wu QJ, Xie CH, Zhang G. Long-term survival of patients with hepatocellular carcinoma with pulmonary and adrenal metastasis: A case report. Exp Ther Med 2012;3:699-702. [PMID: 22969954 DOI: 10.3892/etm.2012.455] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
58 Sasaki R, Kanda T, Fujisawa M, Matsumoto N, Masuzaki R, Ogawa M, Matsuoka S, Kuroda K, Moriyama M. Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines. Int J Mol Sci 2020;21:E3349. [PMID: 32397371 DOI: 10.3390/ijms21093349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
59 Brito AF, Mendes M, Abrantes AM, Tralhão JG, Botelho MF. Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose. Mol Diagn Ther 2014;18:495-504. [PMID: 24852041 DOI: 10.1007/s40291-014-0106-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
60 Baba Y, Hayashi S, Ueno K, Nakajo M, Ueno S, Kubo F, Baba Y, Hamanoue M, Hasegawa S, Tsubouchi H, Komorizono Y. Comparison of survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma. Oncol Lett 2010;1:905-11. [PMID: 22966404 DOI: 10.3892/ol_00000161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Machida K. Existence of cancer stem cells in hepatocellular carcinoma: myth or reality? Hepatol Int. 2017;11:143-147. [PMID: 27990610 DOI: 10.1007/s12072-016-9777-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
62 Meng Z, Wang X, Gan Y, Zhang Y, Zhou H, Ness CV, Wu J, Lou G, Yu H, He C, Xu R, Huang W. Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice. J Hepatol 2012;57:1004-12. [PMID: 22728874 DOI: 10.1016/j.jhep.2012.06.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
63 Li PY, Lin JS, Feng ZH, He YF, Zhou HJ, Ma X, Cai XK, Tian DA. Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma. World J Gastroenterol 2004; 10(15): 2195-2200 [PMID: 15259064 DOI: 10.3748/wjg.v10.i15.2195] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
64 Alvite-Canosa M, Pita-Fernández S, Quintela-Fandiño J, Aguirrezabalaga J, Corbal G, Fernández C, Suárez F, Otero A, Gómez-Gutiérrez M. Prognostic and developmental factors in patients receiving liver transplant due to hepatocellular carcinoma: one center's experience in the north of Spain. Transplant Proc 2010;42:4578-81. [PMID: 21168741 DOI: 10.1016/j.transproceed.2010.09.161] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Liu N, Meng Z, Lou G, Zhou W, Wang X, Zhang Y, Zhang L, Liu X, Yen Y, Lai L. Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression. Mol Endocrinol. 2012;26:775-785. [PMID: 22474109 DOI: 10.1210/me.2011-1383] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 6.5] [Reference Citation Analysis]
66 Colomer C, Marruecos L, Vert A, Bigas A, Espinosa L. NF-κB Members Left Home: NF-κB-Independent Roles in Cancer. Biomedicines 2017;5:E26. [PMID: 28587092 DOI: 10.3390/biomedicines5020026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
67 Alvite Canosa M, Pita Fernández S, Quintela Fandiño J, Aguirrezabalaga J, Otero A, Suárez F, Corbal G, Fernández C, Gutiérrez MG. [Surgical treatment of liver cancer: experience of the A Coruña UHC (Spain)]. Cir Esp 2011;89:223-9. [PMID: 21353668 DOI: 10.1016/j.ciresp.2010.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
68 Schmitz V, Tirado-Ledo L, Raskopf E, Rabe C, Wernert N, Wang L, Prieto J, Qian C, Sauerbruch T, Caselmann WH. Effective antitumour mono- and combination therapy by gene delivery of angiostatin-like molecule and interleukin-12 in a murine hepatoma model. Int J Colorectal Dis 2005;20:494-501. [PMID: 15864607 DOI: 10.1007/s00384-004-0727-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
69 Zhao P, Yang X, Qi S, Liu H, Jiang H, Hoppmann S, Cao Q, Chua MS, So SK, Cheng Z. Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes. Biomed Res Int 2013;2013:759057. [PMID: 23710458 DOI: 10.1155/2013/759057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
70 Szabo G, Wands JR, Eken A, Osna NA, Weinman SA, Machida K, Joe Wang H. Alcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage. Alcohol Clin Exp Res 2010;34:1675-86. [PMID: 20608905 DOI: 10.1111/j.1530-0277.2010.01255.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
71 Dorfman JD, Schulick R, Choti MA, Geschwind JFH, Kamel I, Torbenson M, Thuluvath PJ. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol 2007; 13(5): 781-784 [PMID: 17278203 DOI: 10.3748/wjg.v13.i5.781] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
72 Liu L, Dong X, Zhu D, Song L, Zhang H, Leng XG. TAT-LHRH conjugated low molecular weight chitosan as a gene carrier specific for hepatocellular carcinoma cells. Int J Nanomedicine 2014;9:2879-89. [PMID: 24959076 DOI: 10.2147/IJN.S61392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
73 Gür A, Oguzturk H, Köse A, Turtay MG, Ersan V, Bayindir Y, Ince V, Gurbuz S, Yucel N. Prognostic Value of Procalcitonin, CRP, Serum Amyloid A, Lactate and IL-6 Markers in Liver Transplant Patients Admitted to ED with Suspected Infection. In Vivo 2017;31:1179-85. [PMID: 29102943 DOI: 10.21873/invivo.11187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
74 Chen Y, Li HH, Fu J, Wang XF, Ren YB, Dong LW, Tang SH, Liu SQ, Wu MC, Wang HY. Oncoprotein p28GANK binds to RelA and retains NF-κB in the cytoplasm through nuclear export. Cell Res 2007. [DOI: 10.1038/sj.cr.2007.99] [Reference Citation Analysis]
75 Dong Y, Liu Y, Kou X, Jing Y, Sun K, Sheng D, Yu G, Yu D, Zhao Q, Zhao X, Li R, Wu M, Wei L. The protective or damaging effect of Tumor necrosis factor-α in acute liver injury is concentration-dependent. Cell Biosci 2016;6:8. [PMID: 26843922 DOI: 10.1186/s13578-016-0074-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
76 Chen E, Xu X, Liu R, Liu T. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression. Biomed Res Int 2018;2018:6784607. [PMID: 29951542 DOI: 10.1155/2018/6784607] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
77 Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14(27): 4300-4308 [PMID: 18666317 DOI: 10.3748/wjg.14.4300] [Cited by in CrossRef: 408] [Cited by in F6Publishing: 377] [Article Influence: 29.1] [Reference Citation Analysis]
78 Yang X, Liu H, Sun CK, Natarajan A, Hu X, Wang X, Allegretta M, Guttmann RD, Gambhir SS, Chua MS, Cheng Z, So SK. Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody. Biomaterials 2014;35:6964-71. [PMID: 24836949 DOI: 10.1016/j.biomaterials.2014.04.089] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
79 Gallicchio R, Nardelli A, Mainenti P, Nappi A, Capacchione D, Simeon V, Sirignano C, Abbruzzi F, Barbato F, Landriscina M. Therapeutic Strategies in HCC: Radiation Modalities. Biomed Res Int. 2016;2016:1295329. [PMID: 27563661 DOI: 10.1155/2016/1295329] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
80 Khan R, Zahid S, Wan YJ, Forster J, Karim AB, Nawabi AM, Azhar A, Rahman MA, Ahmed N. Protein expression profiling of nuclear membrane protein reveals potential biomarker of human hepatocellular carcinoma. Clin Proteomics 2013;10:6. [PMID: 23724895 DOI: 10.1186/1559-0275-10-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
81 Zhu X, Qin X, Fei M, Hou W, Greshock J, Bachman KE, Wooster R, Kang J, Qin CY. Combined phosphatase and tensin homolog (PTEN) loss and fatty acid synthase (FAS) overexpression worsens the prognosis of Chinese patients with hepatocellular carcinoma. Int J Mol Sci. 2012;13:9980-9991. [PMID: 22949843 DOI: 10.3390/ijms13089980] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
82 Chen J, Chen Z, Huang Z, Yu H, Li Y, Huang W. Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway. Med Sci Monit 2019;25:4474-84. [PMID: 31203308 DOI: 10.12659/MSM.916202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
83 Machida K. NANOG-Dependent Metabolic Reprogramming and Symmetric Division in Tumor-Initiating Stem-like Cells. Adv Exp Med Biol 2018;1032:105-13. [PMID: 30362094 DOI: 10.1007/978-3-319-98788-0_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Kurokohchi K, Deguchi A, Masaki T, Himoto T, Yoneyama H, Kobayashi M, Maeta T, Kiuchi T, Kohi F, Miyoshi H, Taminato T, Kuriyama S. Successful treatment of hypovascular advanced hepatocellular carcinoma with lipiodol-targetting intervention radiology. World J Gastroenterol 2007; 13(32): 4398-4400 [PMID: 17708619 DOI: 10.3748/wjg.v13.i32.4398] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
85 Ocker M, Alajati A, Ganslmayer M, Zopf S, Lüders M, Neureiter D, Hahn EG, Schuppan D, Herold C. The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells. J Cancer Res Clin Oncol. 2005;131:385-394. [PMID: 15754201 DOI: 10.1007/s00432-004-0664-6] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 3.1] [Reference Citation Analysis]
86 Fahey BJ, Nelson RC, Bradway DP, Hsu SJ, Dumont DM, Trahey GE. In vivo visualization of abdominal malignancies with acoustic radiation force elastography. Phys Med Biol. 2008;53:279-293. [PMID: 18182703 DOI: 10.1088/0031-9155/53/1/020] [Cited by in Crossref: 124] [Cited by in F6Publishing: 107] [Article Influence: 8.3] [Reference Citation Analysis]
87 Bisteau X, Caldez MJ, Kaldis P. The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations. Cancers (Basel) 2014;6:79-111. [PMID: 24419005 DOI: 10.3390/cancers6010079] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 5.5] [Reference Citation Analysis]
88 Eskander EF, Abd-Rabou AA, Yahya SM, El Sherbini A, Mohamed MS, Shaker OG. "P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences". Indian J Clin Biochem 2014;29:3-7. [PMID: 24478542 DOI: 10.1007/s12291-013-0317-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
89 Ren FY, Piao XX, Jin AL. Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma. World J Gastroenterol 2006; 12(29): 4656-4659 [PMID: 16937435 DOI: 10.3748/wjg.v12.i29.4656] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
90 Cui J, Nan KJ, Tian T, Guo YH, Zhao N, Wang L. Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture. World J Gastroenterol 2007; 13(41): 5432-5439 [PMID: 17907285 DOI: 10.3748/wjg.v13.i41.5432] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
91 Xu Q, Gu S, Liang J, Lin Z, Zheng S, Yan J. The Biological Function of Hepatitis B Virus X Protein in Hepatocellular Carcinoma. Oncol Res 2019;27:509-14. [PMID: 29891022 DOI: 10.3727/096504018X15278771272963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
92 Li X, Pan Y, Fan R, Jin H, Han S, Liu J, Wu K, Fan D. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo. Carcinogenesis. 2008;29:1587-1593. [PMID: 18299278 DOI: 10.1093/carcin/bgn052] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
93 Doan CC, Doan NT, Nguyen QH, Nguyen MH, Do MS, Le VD. Downregulation of Kinesin spindle protein inhibits proliferation, induces apoptosis and increases chemosensitivity in hepatocellular carcinoma cells. Iran Biomed J 2015;19:1-16. [PMID: 25605484 DOI: 10.6091/ibj.1386.2014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Liu SF, Hsieh MH, Hou NJ, Hsieh MY, Huang JF, Dai CY, Yu ML, Chuang WL. Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan. Hepatol Int 2010;4:601-7. [PMID: 21063483 DOI: 10.1007/s12072-010-9198-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
95 Rand D, Ortiz V, Liu Y, Derdak Z, Wands JR, Tatíček M, Rose-Petruck C. Nanomaterials for X-ray imaging: gold nanoparticle enhancement of X-ray scatter imaging of hepatocellular carcinoma. Nano Lett 2011;11:2678-83. [PMID: 21644516 DOI: 10.1021/nl200858y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
96 Zhang Y, Li Y, Lin C, Ding J, Liao G, Tang B. Aberrant upregulation of 14-3-3σ and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma. PLoS One 2014;9:e107251. [PMID: 25226601 DOI: 10.1371/journal.pone.0107251] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
97 Zyoud SH. Global scientific trends on aflatoxin research during 1998-2017: a bibliometric and visualized study. J Occup Med Toxicol. 2019;14:27. [PMID: 31832075 DOI: 10.1186/s12995-019-0248-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
98 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(7): 1740-1742 [DOI: 10.11569/wcjd.v12.i7.1740] [Reference Citation Analysis]
99 Zhang G, Long M, Wu ZZ, Yu WQ. Mechanical properties of hepatocellular carcinoma cells. World J Gastroenterol 2002; 8(2): 243-246 [PMID: 11925600 DOI: 10.3748/wjg.v8.i2.243] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 65] [Article Influence: 4.0] [Reference Citation Analysis]
100 Chen RC, Wang J, Kuang XY, Peng F, Fu YM, Huang Y, Li N, Fan XG. Integrated analysis of microRNA and mRNA expression profiles in HBx-expressing hepatic cells. World J Gastroenterol 2017; 23(10): 1787-1795 [PMID: 28348484 DOI: 10.3748/wjg.v23.i10.1787] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
101 Chen D, Wang Y, Zhang K, Jiao X, Yan B, Liang J. Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and E-cadherin. Int J Mol Sci 2012;13:10594-607. [PMID: 22949882 DOI: 10.3390/ijms130810594] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
102 Biffi R, Orsi F, Zampino MG, Chiappa A, Fazio N, De Braud F, Bonomo G, Monfardini L, Vigna PD, Luca F, Bodei L, Bartolomei M, Catalano G, Leonardi MC, Ferrari M, Andreoni B, Goldhirsch A, Paganelli G, Orecchia R. Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology. Ecancermedicalscience 2008;2:64. [PMID: 22275961 DOI: 10.3332/eCMS.2008.64] [Reference Citation Analysis]
103 Machida K. Cell fate, metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol. Chem Biol Interact 2020;323:109055. [PMID: 32171851 DOI: 10.1016/j.cbi.2020.109055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Kishimoto H, Urata Y, Tanaka N, Fujiwara T, Hoffman RM. Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses. Mol Cancer Ther 2009;8:3001-8. [PMID: 19887549 DOI: 10.1158/1535-7163.MCT-09-0556] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
105 Schmitz V, Qian C, Ruiz J, Sangro B, Melero I, Mazzolini G, Narvaiza I, Prieto J. Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies. Gut 2002;50:130-5. [PMID: 11772981 DOI: 10.1136/gut.50.1.130] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
106 Tanwar S, Khan SA, Grover VPB, Gwilt C, Smith B, Brown A. Liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2009; 15(44): 5511-5516 [PMID: 19938188 DOI: 10.3748/wjg.15.5511] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
107 Borum ML. Unusual development of hepatocellular carcinoma in a patient with Crohn's disease. Dig Dis Sci 2001;46:2199-200. [PMID: 11680596 DOI: 10.1023/a:1011915032118] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
108 Peng C, Zhou RL, Shao GZ, Rui JA, Wang SB, Lin M, Zhang S, Gao ZF. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. World J Gastroenterol 2005; 11(18): 2704-2708 [PMID: 15884107 DOI: 10.3748/wjg.v11.i18.2704] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
109 Ozaki I, Hamajima H, Matsuhashi S, Mizuta T. Regulation of TGF-β1-induced pro-apoptotic signaling by growth factor receptors and extracellular matrix receptor integrins in the liver. Front Physiol. 2011;2:78. [PMID: 22028694 DOI: 10.3389/fphys.2011.00078] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
110 Ling X, Zhou Y, Li SW, Yan B, Wen L. Modulation of mitochondrial permeability transition pore affects multidrug resistance in human hepatocellular carcinoma cells. Int J Biol Sci 2010;6:773-83. [PMID: 21152118 DOI: 10.7150/ijbs.6.773] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
111 Morisco F, Stigliano R, Godfrey A, Leandro G, Patch D, Davidson B, Rolles K, Dhillon A, Dhillon AP, Quaglia A. Efficacy of loco-regional ablation therapy of HCC in a population of liver transplanted patients. Dig Dis Sci. 2008;53:1131-1137. [PMID: 17934816 DOI: 10.1007/s10620-007-9986-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
112 Song TJ, Eisenberg DP, Adusumilli PS, Hezel M, Fong Y. Oncolytic herpes viral therapy is effective in the treatment of hepatocellular carcinoma cell lines. J Gastrointest Surg. 2006;10:532-542. [PMID: 16627219 DOI: 10.1016/j.gassur.2005.08.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
113 Doan CC, Le LT, Hoang SN, Do SM, Le DV. Simultaneous silencing of VEGF and KSP by siRNA cocktail inhibits proliferation and induces apoptosis of hepatocellular carcinoma Hep3B cells. Biol Res 2014;47:70. [PMID: 25723613 DOI: 10.1186/0717-6287-47-70] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
114 Spangenberg HC, Thimme R, Blum HE. Evolving therapies in the treatment of hepatocellular carcinoma. Biologics 2008;2:453-62. [PMID: 19707376 DOI: 10.2147/btt.s3254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
115 Yacoub H, Kchir H, Cherif D, Hassine H, Haouet S, Ayari A, Mizouni H, Mannai S, Khalfallah MT, Maamouri N. Hepatocellular carcinoma arising from hepatic adenoma in a young woman. Clin Case Rep 2020;8:1659-62. [PMID: 32983471 DOI: 10.1002/ccr3.2975] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Pines M. Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract. World J Gastroenterol 2014; 20(40): 14778-14786 [PMID: 25356039 DOI: 10.3748/wjg.v20.i40.14778] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
117 Tang B, Hu Z, Li Y, Yuan S, Wang Z, Yu S, He S. Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU. Mol Med Rep 2016;13:59-66. [PMID: 26549838 DOI: 10.3892/mmr.2015.4511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
118 Okuwaki Y, Nakazawa T, Shibuya A, Ono K, Hidaka H, Watanabe M, Kokubu S, Saigenji K. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns. J Gastroenterol. 2008;43:71-78. [PMID: 18297439 DOI: 10.1007/s00535-007-2123-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 3.9] [Reference Citation Analysis]
119 Tan GH, Huang FY, Wang H, Huang YH, Lin YY, Li YN. Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin. World J Gastroenterol 2007; 13(17): 2479-2483 [PMID: 17552032 DOI: 10.3748/wjg.v13.i17.2479] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
120 Bertagna F, Bertoli M, Bosio G, Biasiotto G, Sadeghi R, Giubbini R, Treglia G. Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis. Hepatol Int 2014;8:493-500. [PMID: 26202754 DOI: 10.1007/s12072-014-9566-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
121 Wang Q, Zhou J, Zhong D, Wang Q, Huang J. Ferroportin in the progression and prognosis of hepatocellular carcinoma. Eur J Med Res 2013;18:59. [PMID: 24360312 DOI: 10.1186/2047-783X-18-59] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
122 Mondragón-sánchez R, Lilia Garduño-lópez A, Gómez-gómez E, Frias-mendivil M, Mondragón-sánchez A, Bernal-maldonado R. Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm. Annals of Hepatology 2005;4:200-3. [DOI: 10.1016/s1665-2681(19)32066-6] [Reference Citation Analysis]
123 Mohd Azamai ES, Sulaiman S, Mohd Habib SH, Looi ML, Das S, Abdul Hamid NA, Wan Ngah WZ, Mohd Yusof YA. Chlorella vulgaris triggers apoptosis in hepatocarcinogenesis-induced rats. J Zhejiang Univ Sci B 2009;10:14-21. [PMID: 19198018 DOI: 10.1631/jzus.B0820168] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
124 Zhou ZQ, Manguino D, Kewitt K, Intano GW, McMahan CA, Herbert DC, Hanes M, Reddick R, Ikeno Y, Walter CA. Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase. Proc Natl Acad Sci U S A 2001;98:12566-71. [PMID: 11606727 DOI: 10.1073/pnas.221232998] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
125 Shao J, Shi CJ, Li Y, Zhang FW, Pan FF, Fu WM, Zhang JF. LincROR Mediates the Suppressive Effects of Curcumin on Hepatocellular Carcinoma Through Inactivating Wnt/β-Catenin Signaling. Front Pharmacol 2020;11:847. [PMID: 32714183 DOI: 10.3389/fphar.2020.00847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
126 Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM, Zheng SS. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29:1810-1816. [PMID: 21678027 DOI: 10.1007/s12032-011-0004- z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Chen Q, Chen Z, Cao S, Guo B, Chen Y, Feng Z, Wang J, Guo G, Chen X, Huang X. Role of CircRNAs_100395 in Proliferation and Metastases of Liver Cancer. Med Sci Monit 2019;25:6181-92. [PMID: 31421050 DOI: 10.12659/MSM.915963] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
128 Luedde T, Schwabe RF. NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2011;8:108-18. [PMID: 21293511 DOI: 10.1038/nrgastro.2010.213] [Cited by in Crossref: 673] [Cited by in F6Publishing: 667] [Article Influence: 61.2] [Reference Citation Analysis]
129 de Oliveira RM, Ornelas Ricart CA, Araujo Martins AM. Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma. Front Oncol. 2017;7:328. [PMID: 29379771 DOI: 10.3389/fonc.2017.00328] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
130 He L, Tian DA, Li PY, He XX. Mouse models of liver cancer: Progress and recommendations. Oncotarget 2015;6:23306-22. [PMID: 26259234 DOI: 10.18632/oncotarget.4202] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 8.3] [Reference Citation Analysis]
131 Li SG, Shi QW, Yuan LY, Qin LP, Wang Y, Miao YQ, Chen Z, Ling CQ, Qin WX. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells. J Exp Clin Cancer Res 2018;37:51. [PMID: 29523159 DOI: 10.1186/s13046-018-0698-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
132 Wang AG, Fang W, Han YH, Cho SM, Choi JY, Lee KH, Kim WH, Kim JM, Park MG, Yu DY, Kim NS, Lee DS. Expression of the RERG gene is gender-dependent in hepatocellular carcinoma and regulated by histone deacetyltransferases. J Korean Med Sci 2006;21:891-6. [PMID: 17043425 DOI: 10.3346/jkms.2006.21.5.891] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
133 Liu C, Zhou N, Li J, Kong J, Guan X, Wang X. Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients. Dis Markers 2017;2017:2176460. [PMID: 28684886 DOI: 10.1155/2017/2176460] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
134 Sami H, Rizvi M, Azam M, Mukherjee RM, Shukla I, Ajmal MR, Malik A. Emergence of hepatitis B virus genotype f in aligarh region of north India. Adv Virol 2013;2013:846849. [PMID: 24381592 DOI: 10.1155/2013/846849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]